Published in Am J Physiol on May 01, 1986
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD) | NCT01398943
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Flow-mediated endothelial mechanotransduction. Physiol Rev (1995) 10.13
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A (2004) 4.81
Endothelial dysfunction in diabetes. Br J Pharmacol (2000) 3.13
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61
Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A (1991) 2.39
The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J (2002) 2.09
Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest (1990) 1.99
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest (1991) 1.96
Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev (2008) 1.91
Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci U S A (1991) 1.87
Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle. Br J Pharmacol (1987) 1.70
Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A (1996) 1.64
Endothelium-dependent contractions in hypertension. Br J Pharmacol (2005) 1.59
Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest (1987) 1.55
The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles. Br J Pharmacol (1990) 1.54
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol (2011) 1.51
The vascular endothelium and human diseases. Int J Biol Sci (2013) 1.49
Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol (1988) 1.45
St Cyres lecture. Endothelium in control. Br Heart J (1991) 1.43
Cellular signaling and NO production. Pflugers Arch (2010) 1.38
Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest (1995) 1.36
Effect of nitric oxide on circular muscle of the canine small intestine. J Physiol (1991) 1.34
Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest (1995) 1.34
Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest (1988) 1.34
The vascular endothelium. A new horizon. Ann Surg (1993) 1.32
Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc Natl Acad Sci U S A (1992) 1.31
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol (2000) 1.25
Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J Physiol (2005) 1.20
Tissue vibration induces carotid artery endothelial dysfunction: a mechanism linking snoring and carotid atherosclerosis? Sleep (2011) 1.20
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A (1994) 1.20
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart (2002) 1.17
Coronary blood flow responses to physiological stress in humans. Am J Physiol Heart Circ Physiol (2009) 1.16
Redox signaling in cardiovascular health and disease. Free Radic Biol Med (2013) 1.16
Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers (2013) 1.16
Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol (1993) 1.14
Local regulation of arterial L-type calcium channels by reactive oxygen species. Circ Res (2010) 1.13
Human extracellular superoxide dismutase is a tetramer composed of two disulphide-linked dimers: a simplified, high-yield purification of extracellular superoxide dismutase. Biochem J (1996) 1.13
Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol (1990) 1.12
Adventures in vascular biology: a tale of two mediators. Philos Trans R Soc Lond B Biol Sci (2006) 1.10
Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci (2008) 1.10
Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.09
Ketorolac alters blood flow during normothermia but not during hyperthermia in middle-aged human skin. J Appl Physiol (1985) (2009) 1.09
Vasoconstrictor prostanoids. Pflugers Arch (2010) 1.09
Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. J Physiol (1992) 1.08
Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery. Br J Pharmacol (1991) 1.08
NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol (2011) 1.08
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci U S A (1993) 1.08
Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest (2003) 1.08
Endothelium-dependent contractions: when a good guy turns bad! J Physiol (2008) 1.08
Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol (2006) 1.07
Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci (2011) 1.06
Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mol Med (Berl) (2009) 1.05
The effects of acute oral antioxidants on diving-induced alterations in human cardiovascular function. J Physiol (2006) 1.05
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest (1998) 1.05
Human endothelial dysfunction: EDRFs. Pflugers Arch (2010) 1.04
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension (2012) 1.04
Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A (1996) 1.04
Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med (2010) 1.04
Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch (2010) 1.04
Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev (2003) 1.03
Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle. Br J Pharmacol (1999) 1.03
Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci U S A (2004) 1.03
Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester. Br J Pharmacol (1990) 1.02
Endothelial nitric oxide: protector of a healthy mind. Eur Heart J (2013) 1.01
Non-adrenergic, non-cholinergic relaxation of the bovine retractor penis muscle: role of S-nitrosothiols. Br J Pharmacol (1994) 1.00
COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol Sin (2010) 0.99
Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med (2005) 0.98
Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol (1993) 0.98
The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles. Br J Pharmacol (2006) 0.98
Angiotensin II and nitric oxide interaction. Heart Fail Rev (2002) 0.98
Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta. Br J Pharmacol (1995) 0.97
Induction by endothelin-1 of epithelium-dependent relaxation of guinea-pig trachea in vitro: role for nitric oxide. Br J Pharmacol (1993) 0.96
The role of adenosine in mediating vasodilatation in mesenteric circulation of the rat in acute and chronic hypoxia. J Physiol (1995) 0.96
Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells. Br J Pharmacol (1989) 0.96
Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol (2012) 0.96
Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta. Br J Pharmacol (1988) 0.96
Ascorbate blocks endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and rat mesentery. Br J Pharmacol (2002) 0.96
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol (1999) 0.95
Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells. Br J Pharmacol (1991) 0.95
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta. Br J Pharmacol (1999) 0.94
Ultra-low microcurrent in the management of diabetes mellitus, hypertension and chronic wounds: report of twelve cases and discussion of mechanism of action. Int J Med Sci (2009) 0.94
Role of estrogen in diastolic dysfunction. Am J Physiol Heart Circ Physiol (2014) 0.93
Vitamin C prevents hyperoxia-mediated coronary vasoconstriction and impairment of myocardial function in healthy subjects. Eur J Appl Physiol (2011) 0.93
TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide. BMC Gastroenterol (2001) 0.91
The behaviour of muscle microcirculation in chronically hypoxic rats: the role of adenosine. J Physiol (1996) 0.91
Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite. Biochim Biophys Acta (2013) 0.91
Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Hypertens (2010) 0.89
Endothelium-derived free radicals: for worse and for better. J Clin Invest (2001) 0.88
Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol (1996) 0.88
Mechanisms of endothelial dysfunction after ionized radiation: selective impairment of the nitric oxide component of endothelium-dependent vasodilation. Br J Pharmacol (2003) 0.88
Regulation of vascular smooth muscle tone by adipose-derived contracting factor. PLoS One (2013) 0.88
Nitric oxide function in atherosclerosis. Mediators Inflamm (1997) 0.87
Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res (2011) 0.87
Bang-bang model for regulation of local blood flow. Microcirculation (2013) 0.87
Endothelium-derived relaxing and contracting factors. FASEB J (1989) 7.22
Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J Physiol (1981) 3.92
Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol (1988) 3.88
Flow-induced release of endothelium-derived relaxing factor. Am J Physiol (1986) 3.51
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther (1981) 3.47
Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther (1982) 3.33
Endothelial dysfunction in diabetes. Br J Pharmacol (2000) 3.13
Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res (1982) 2.76
Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol (1986) 2.76
Local modulation of adrenergic neuroeffector interaction in the blood vessel well. Physiol Rev (1981) 2.54
Respiratory epithelium inhibits bronchial smooth muscle tone. J Appl Physiol (1985) (1985) 2.45
Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol (1986) 2.42
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension (1986) 2.30
Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium. Circ Res (1999) 2.30
Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Circ Res (1977) 2.30
Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol (1988) 2.13
Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol (1985) 2.05
Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine. J Pharmacol Exp Ther (1973) 2.03
Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol (1992) 2.02
Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol (1983) 2.01
Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.94
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A (2000) 1.89
Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries. Br J Pharmacol (1999) 1.75
Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation (1995) 1.71
Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci (1997) 1.68
Interaction between Na+,K+ exchanges and the direct inhibitory effect of acetylcholine on canine femoral arteries. Circ Res (1980) 1.65
Endothelium-removal decreases relaxations of canine coronary arteries caused by beta-adrenergic agonists and adenosine. J Cardiovasc Pharmacol (1985) 1.64
Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther (1987) 1.63
Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle. Circ Res (1974) 1.60
Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res (1989) 1.59
Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. Am J Physiol (1985) 1.59
Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther (1988) 1.57
Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol (1999) 1.55
Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol (1999) 1.54
Uneven distribution of postjunctional alpha 1-and alpha 2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res (1981) 1.53
Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol (1999) 1.53
The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol (1988) 1.53
Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis (1988) 1.52
Superoxide anion is an endothelium-derived contracting factor. Am J Physiol (1989) 1.49
Effects of moderate acidosis on adrenergic neurotransmission in canine saphenous veins. J Pharmacol Exp Ther (1978) 1.48
Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol (1999) 1.47
Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol (1996) 1.46
Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest (1993) 1.46
Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science (1983) 1.45
Role of the endothelium in the control of vascular smooth muscle function. J Physiol (Paris) (1983) 1.44
Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res (1992) 1.42
Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol (1979) 1.41
Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am J Physiol (1992) 1.37
Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol (1998) 1.36
Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol (1989) 1.36
Platelets, endothelium, and vasospasm. Circulation (1985) 1.35
Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol (1985) 1.33
Instantaneous changes of alpha-adrenoceptor affinity caused by moderate cooling in canine cutaneous veins. Am J Physiol (1978) 1.32
Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension (1987) 1.30
Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery. Br J Pharmacol (2000) 1.30
Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468). Eur J Pharmacol (1982) 1.29
Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res (1987) 1.27
Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol (1988) 1.27
5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol (1983) 1.26
L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat. Circ Res (1991) 1.26
Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res (1999) 1.25
Vascular physiology: the end of the quest? Nature (1987) 1.24
Release of different relaxing factors by cultured porcine endothelial cells. Circ Res (1989) 1.24
Membrane potential and Na(+)-K+ pump activity modulate resting and bradykinin-stimulated changes in cytosolic free calcium in cultured endothelial cells from bovine atria. J Biol Chem (1990) 1.23
Determination of 3H-norepinephrine and its metabolites in superfusate from isolated blood vessels. Arch Int Pharmacodyn Ther (1977) 1.23
Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am J Physiol (1991) 1.23
Endothelium-dependent contraction to stretch in canine basilar arteries. Am J Physiol (1987) 1.22
Effects of anoxia and glucose depletion on isolated veins of the dog. Am J Physiol (1976) 1.22
The endothelium--modulator of vascular smooth-muscle tone. N Engl J Med (1988) 1.21
Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther (1984) 1.21
Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20
Endothelium-derived hyperpolarizing factor. Blood Vessels (1990) 1.20
Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am J Physiol (1985) 1.19
International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev (1994) 1.19
Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension (1988) 1.19
Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) (2010) 1.18
Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol (1998) 1.17
Suppression of K(+)-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol (2001) 1.17
Venous relaxation caused by acetylcholine acting on the sympathetic nerves. Circ Res (1973) 1.17
Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol (1995) 1.17
Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J Cardiovasc Pharmacol (1985) 1.16
Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res (1984) 1.16
The alternative: EDHF. J Mol Cell Cardiol (1999) 1.16
Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. Am J Physiol (1985) 1.15
Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. Am J Physiol (1980) 1.15
Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol (2000) 1.14
Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol (2000) 1.14
Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol (1997) 1.14
Inhibitory effects of catecholamine in isolated canine bronchial smooth muscle. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.14
Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation (1991) 1.13
Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites. Am J Physiol (1978) 1.13
Effect of temperature on reactivity of isolated cutaneous veins of the dog. Am J Physiol (1970) 1.13
Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension (1995) 1.13